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ÖZ
Giriş: Obez bireylerde astım prevelansı artmıştır. Çocukluk 
astımında vücut kitle indeksindeki artışın solunum fonksiyonlarını 
kötüleştirdiğini gösteren kesin kanıt yoktur. Amacımız astımlı 
çocuklarda obezite, atopi ve cinsiyetin solunum fonksiyonu üzerine 
etkisini araştırmaktır.
Gereç ve yöntem: Çalışma hafif persistan astımı olan çocuklarda 
yapılan kesitsel bir analizdir. 76 obez astım ve 55 normal kilodaki 
astımlı çocuk çalışmaya alındı. Tüm katılımcılar solunum fonksiyon 
testi ile değerlendirildi. Tüm hastalara sık saptanan aeroallerjenler 
ile deri prick testi yapıldı.
Bulgular: Obez ve normal kilodaki astımlı çocukların solunum 
fonksiyon test parametreleri arasında fark yoktu. Obez astımlı 
hastalarda atopik olmayanların (92.1±6.4) birinci saniyedeki zorlu 
ekspiratuvar volümün zorlu vital kapasiteye oranı (FEV1/FVC) 
atopik (95.5±5.3, p=0.02) olanlara göre daha düşüktü. Aynı zamanda 
atopik olmayan obezlerin (92.1±6.4) FEV1/FVC oranının atopik 
olmayan normal kilodaki astımlı çocuklardan (95.6±4.7) daha 
düşük olduğu saptandı (p=0.05).
Sonuç: Obezitenin iyi kontrollü, hafif persistan astımı olan 
çocukların solunum fonksiyonunu etkilemediği görülmektedir. 
Ancak, atopisi olmayan obez astımlı çocukların hava yolları daha 
fazla etkilenmektedir.
ABSTRACT
Objective: The prevalence of asthma is increased in obese individuals. 
There is no concrete evidence that an increase in body mass index is 
associated with a loss of pulmonary function in childhood asthma. 
Our aim was to investigate the effect of obesity, atopy, and sex on 
pulmonary function in asthmatic children. 
Materials and Methods: This study is a cross-sectional analysis in 
children with mild persistent asthma. A total of 76 obese and 55 lean 
children with asthma were recruited. All of the participants were 
assessed by pulmonary function tests. Skin prick tests including 
common aeroallergens were performed to all patients. 
Results: No differences were found in pulmonary function test 
parameters between obese and lean patients with asthma. In obese 
patients with asthma, the ratio of forced expiratory volume in 1 s 
to forced vital capacity (FEV1/FVC) was significantly lower in 
nonatopic (92.1±6.4) than in atopic patients (95.5±5.3, p=0.02). 
We also demonstrated that FEV1/FVC was significantly lower in 
nonatopic obese patients (92.1±6.4) than in nonatopic lean patients 
with asthma (95.6±4.7, p=0.05). 
Conclusion: Obesity does not seem to be affecting pulmonary 
function in children with well-controlled mild persistent asthma. 
However, airways of nonatopic obese asthmatics are negatively 
affected. 
Anahtar kelimeler: Astım, atopi, obezite, solunum fonksiyonu, 
vücut kitle indeksi
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InTROduCTIOn
Asthma and obesity are increasingly prevalent health 
problems in children and adults (1,2). Cross-sectional 
and case-control studies in children and adults have 
demonstrated an increased prevalence of asthma in obese 
individuals (3-6). Responsible mechanisms include a 
sedentary lifestyle, dietary factors, reduced chest wall 
compliance, insulin resistance, comorbidities, and 
common genetic predisposition (6-8). Since asthma is the 
chronic inflammatory disease of airways, obesity-induced 
chronic inflammation has also been implicated in the lung 
inflammation (9). 
Studies show that pulmonary function measurements 
are required to determine the severity of the asthma and 
obesity may increase severity of asthma (6,10). FEV1/
FVC ratio has been found to have potential relevance in 
the relationship between BMI and asthma severity (11). 
Asthma tends to be more severe in overweight and obese 
children than in normal weight peers (12). A modest 
association has been reported between elevated BMI and a 
reduced therapeutic effect of inhaled corticosteroid (ICS)-
containing regimens in the mild and moderate persistent 
asthma population (13). 
Many investigators have demonstrated effects of 
obesity on lung volumes (6). However, there is no concrete 
evidence that an increase in body mass index (BMI) 
is associated with a loss of lung function in childhood 
asthma, besides the usual effects of obesity on lung volume 
(11,14,15). Normal pulmonary function has been reported 
in childhood asthmatics with increased BMI (3,6,16,17). 
On the other hand, FEV1/FVC decline with increasing 
BMI, indicating that obesity promotes airway obstruction 
and decline in FVC in adults, but no change with BMI or 
even increased FVC with BMI in children have been also 
reported in literature (6) .
A specific interaction of obesity and asthma on 
pulmonary function has not been demonstrated in 
childhood asthma (11,12,15,18). Relationship between 
obesity and asthma were found only in females (6). Effects 
of BMI on the risk of atopy have been examined but the 
effect of atopy on pulmonary functions in obese asthmatics 
has not been descibed (6). 
This study aimed to investigate the effect of obesity on 
pulmonary function in mild persistent asthmatic children 
and how it is modified by sex and atopic disease. 
MATERIAlS and METhODS
Study Population
One hundred thirty-one children with physician-
diagnosed asthma (67 boys and 64 girls, aged between 6-16 
years) from the outpatient clinic of the pediatric allergy 
unit were enrolled in the study. Patients were categorized 
into two groups as obese children with asthma (n=76) 
and lean children with asthma (n=55). We compared the 
groups according to sex and atopy. 
The patients had been previously diagnosed with 
asthma according to the Global Strategy for Asthma 
Management and Prevention Classification (GINA) based 
on a history of intermittent wheezing and demonstration 
of reversible airway obstruction as defined by at least a 12% 
improvement in forced expiratory volume in 1 s (FEV1) 
following bronchodilator administration (19). All children 
had mild persistent, well-controlled asthma at the time of 
evaluation and had been using inhaled corticosteroids of 
either 200 μg fluticasone propionate or 400 μg budesonide. 
Asthma control status was determined according to 
GINA guidelines (19). Children with a history of attacks 
requiring systemic corticosteroids within 3 months and 
having inhaled β2 agonist at the day of pulmonary function 
test were excluded from the study.
All of the participants were assessed by a physical 
examination. Each patient’s height was measured with a 
standard wall-mounted stadiometer. Weight was measured 
with a calibrated electronic scale. BMI was calculated using 
the weight/height2 (kg/m2) formula. Children with a BMI 
above the 95th percentile for age and sex were defined 
as obese (as defined by the National Center for Health 
Statistics, www.cdc.gov). Relative BMI (relBMI) was 
calculated using the following formula: patient’s BMI × 
100/50th percentile BMI for the patient’s age and sex (20). 
Children with a relBMI ≥120 were defined as obese and 
children with a relBMI<110 were defined as lean (20). 
Puberty and growth spurt are related with increased 
BMI and increased volumes that affect pulmonary 
function. Obese subjects with early-onset asthma (<12 
years) are characterized by a higher level of airway 
obstruction compared with obese subjects with late-onset 
asthma (>12 years) (21). Since PFT results are affected, we 
evaluated children younger (pre-pubertal age) and older 
than 10 years and 12 years. 
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Complete Blood Count
Two ml of blood was drawn into a tube anticoagulated 
with ethylenediaminetetraacetic acid and then evaluated 
with a hemocytometer (Abbott Cell-Dyn 3700 system, 
Abbott Diagnostics, Santa Clara, CA, USA) that was 
calibrated daily. Total eosinophil count and eosinophil 
percentages were recorded. 
Skin Prick Test
All patients had skin prick tests (SPT) to aeroallergens 
including D. farinae, D. pteronyssinus, Alternaria, 
Cladosporium, cat, grass mix, weed mix, and tree mix 
allergens (Stallergenes, France). Negative and positive 
control for prick tests were also performed. Atopy was 
defined by a positive skin prick test (SPTs were considered 
positive if the mean diameter of wheal was ≥3 mm) (22). 
Pulmonary Function Test
All of the participants were assessed by pulmonary 
function tests. Pulmonary function tests were performed 
by using the spirometry (Flowhandy ZAN 100 USB, 
Germany). The test results including % predicted values 
of forced vital capacity (FVC), FEV1, the FEV1/FVC 
ratio, and forced expiratory flow (FEF) at 25-75% were 
recorded. Immediately prior to testing, patients and their 
caregivers were provided standardized instructions on the 
technique of performing forced expiratory maneuvers. An 
adequate test required a minimum of three acceptable FVC 
manoeuvres. While performing spirometry, a minimum of 
three flow-volume loop results were obtained. Acceptable 
repeatability is achieved when the difference between the 
largest and the next largest FVC was ≤0.150 L and the 
difference between the largest and next largest FEV1 was 
≤0.150 L. Efforts were free from artifacts including cough 
during the first second of exhalation, glottis closure that 
influences the measurement, early termination or cut-off, 
leak and obstructed mouthpiece. Duration of 3 seconds 
exhalation was needed for children. The  extrapolated 
volume was less than 150 mL or 5% of the FVC, whichever 
was greater (23). 
This study was approved by the Institutional Review 
Board and Ethics Committee. Written informed consent 
was obtained from each patient and/or their parents.
Statistical Analysis
Data were analyzed using SPSS 17.0 statistical software 
(SSPS Inc., Chicago, IL, USA). The results of statistical 
analysis were expressed as the number of observations 
(n) and mean ± standard deviation (SD). Shapiro-Wilk’s 
test was used to assess the normality of distribution of 
the variables, and Levene’s test was used to assess the 
homogeneity of variance among the groups. Comparisons 
of group means were performed with factorial analysis 
of variance and Tukey’s HSD multiple comparison 
tests. Correlations between variables were evaluated by 
Spearman’s rho correlation coefficient. The chi-square test 
was used for comparison of frequencies. A p value <0.05 
was considered statistically significant.
In a one-way ANOVA study, sample sizes of 53, 34, 23, 
and 22 were obtained from the 4 groups and their means 
were compared. The total sample of 131 subjects achieves 
86% power to detect differences among the means versus 
the alternative of equal means using an F test with a 0.05 
significance level. The size of the variation in the means 
was represented by their standard deviation which is 
1.63. The common standard deviation within a group was 
assumed to be 5.16. 
RESUlTS
Obese patients with asthma including 44 boys and 32 
girls and lean patients with asthma including 26 boys and 
29 girls were participated in the study. The distrubition 
of sex was not significantly different between the groups. 
Clinical characteristics of children with asthma are shown 
in Table I. No significant differences were observed in 
age, duration of disease, atopy, or prior use of inhaled 
corticosteroids between obese and lean patients with 
asthma. Allergic rhinitis, family history of asthma and 
pets at home were more frequent in obese children with 
asthma (Table I). RelBMI was significantly higher in obese 
patients than in lean patients with asthma (141±15.8 vs 
97.5±7.8, p<0.001). 
No significant differences were found in FEV1, FVC, 
the FEV1/FVC ratio, and FEF 25-75 values between obese 
and lean patients with asthma (Table I). We also compared 
the groups according to sex for mean FEV1, FVC, the 
FEV1/FVC ratio, and FEF 25-75% and did not find any 
differences either between or within the groups (Table II). 
There was no correlation between relBMI and pulmonary 
function. No correlation was found between relBMI and 
pulmonary function test parameters for girls or boys.
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Table I. Characteristics of obese and lean patients with asthma
Obese patients with asthma lean patients with asthma p
Patients (n) 76 55
Age (year) 9.8±2.6 9.5±2.8 0.540
Sex (M/F) 44/32 26/29 0.150
BMI (kg/m2) 24.5±3.7 16.7±1.7 <0.001
RelBMI 141±15.8 97.5±7.8 <0.001
duration of asthma (month) 37.3±27.4 27.7±28.3 0.060
Presence of atopy 53 (70) 33 (60) 0.200
Total eosinophil count 312.4±305.3 276.7±301.6 0.510
Eosinophils (%) 4.2±3.6 3.4±2.5 0.180
Allergic rhinitis 46 (60.5) 44 (80) 0.030
Family history of asthma 31 (40.8) 14 (25.5) 0.040
Family history of allergies 50 (65.8) 38 (69,1) 0.420
Passive smoking 16 (21) 8 (14.5) 0.240
Pet at home 8 (10.5) 1 (1.8) 0.050
Pulmonary function test
FVC % 92.4±14.2 92.3±12.1 0.960
FEV1 % 102.3±14.3 104.4±12.9 0.410
FEV1/FVC 94.5±5.8 96.1±4.4 0.080
FEF 25-75% 107.3±23.2 111.6±25.5 0.310
BMI: Body mass index, relBMI: Relative BMI, FEV1: Forced expiratory volume in 1 second, FEF: Forced expiratory flow, FVC: Forced vital 
capacity. Values are mean ± SD or number (%) unless otherwise indicated.
Table II. Comparison of pulmonary function test results according to sex
Obese patients with asthma p* lean patients with asthma p* p¶
Male Female Male Female
Patients(n) 44 32 26 29
BMI 24.9±3.8 24±3.5 0.32 16.5±1.5 16.9±1.8 0.40 <0.001
relBMI 143.1±17.3 138.1±13.3 0.17 97.2±7.2 97.8±8.3 0.76 <0.001
Pulmonary function test
FVC % 90.3±13.2 95.3±15.2 0.14 89.9±11.9 94.4±12 0.17 0.38
FEV1 % 100.9±14.3 104.3±14.2 0.32 103.3±12.8 105.3±13.2 0.56 0.58
FEV1/FVC 94.5±6.0 94.3±5.5 0.88 96.1±4.5 96.1±4.5 0.99 0.54
FEF25-75% 109.2±25 104.6±20.6 0.40 112.9±24.2 110.5±27.1 0.73 0.53
FEV1: Forced expiratory volume in 1 second, FEF: Forced expiratory flow, FVC: Forced vital capacity.
Values are mean ± SD unless otherwise indicated.
*p= comparison of males and females within the group.
¶p= comparison of four groups.
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Atopic patients were compared with nonatopic patients 
to evaluate the effect of atopy on pulmonary function 
in obese and lean children with asthma. In lean patients 
with asthma, pulmonary function parameters were not 
significantly different between atopic and nonatopic 
patients. However, in obese patients with asthma, the 
FEV1/FVC ratio was significantly lower in nonatopic 
than in atopic patients (p=0.02). The FEV1/FVC ratio 
was also significantly lower in nonatopic obese patients 
with asthma than in nonatopic lean patients with asthma 
(p=0.05). There was no significant difference in the FEV1/
FVC ratio between atopic lean and atopic obese patients 
with asthma (Table III). 
In obese patients with asthma, only eight had onset of 
asthma at ≥12 years and 15 patients had onset of asthma at 
≥10 years. In lean patients, five had onset of asthma at ≥12 
years and 13 had onset of asthma at ≥10 years. There was 
no correlation between PFT results and duration of disease 
in obese and lean children with asthma. We also could not 
find any correlation between PFT results and duration of 
disease in atopic obese, non atopic obese, atopic lean and 
nonatopic lean children with asthma. There was negative 
correlation between duration of asthma and FEF 25-75 
in children whose asthma had started <10 years in both 
obese and lean asthmatics (Spearman rho=-0.28 and -0.33, 
respectively, p<0.05).
dISCuSSIOn
We investigated the effect of relBMI on pulmonary 
function in patients with asthma and examined whether 
the presence of atopy or sex differences affect pulmonary 
function. In our study, we did not find any differences in 
FEV1, FVC, FEV1/FVC ratio, and FEF 25-75% between 
obese and lean subjects with asthma. 
A previous study showed that FEV1 and FVC were 
significantly reduced in overweight/obese children 
compared with normal weight children (14). Ulger et 
al. (17) reported that FVC, FEV1, and FEF 25-75% were 
lower in obese subjects than in nonobese subjects, but 
the FEV1/FVC ratio was similar. Overall, the discrepancy 
among these study results can be explained by different 
ages, degree of asthma severity, control status and/or 
regular use of inhaled steroid treatment of subjects with 
asthma. Additionally, this variety could be due to using 
different BMI cut-off points, BMI z scores or using relBMI 
for classifying obese children. BMI cut off points that 
define obesity are not linked to age and do not differ for 
males or females. BMI varies with age and sex in children. 
For BMI to be used for grouping or making correlations, it 
should be compared to a reference-standard that accounts 
for child age and sex. Consequently, we recommend 
using relBMI or BMI z scores in children to obtain more 
acccurate results. 
Table III. Comparison of the groups according to atopy
Obese patients with asthma p* lean patients with asthma p* p¶
Atopic nonatopic Atopic nonatopic
Patients(n) 53 23 33 22
BMI 24.2±3.3 25.2±4.3 0.290 16.7±1.6 16.8±1.9 0.800 <0.001
relBMI 140.4±15.2 142.2±17.5 0.660 95.4±8.7 100.7±4.8 0.020 <0.001
Pulmonary function test
FVC % 90.8±13 96.1±16.3 0.140 90.9±12.8 94.2±11.1 0.330 0.380
FEV1 % 101.9±14.2 103.3±14.7 0.710 102.6±13.1 106.7±12.6 0.260 0.580
FEV1/FVC 95.5±5.3 92.1±6.4†‡ 0.020 96.4±4.3† 95.6±4.7‡ 0.530 0.540
FEF25-75% 109.4±24.3 102.3±20.3 0.230 109.6±24.9 113.4±26.7 0.590 0.530
BMI: Body mass index, relBMI: Relative BMI, FEV1: Forced expiratory volume in 1 second, FEF: Forced expiratory flow, FVC: Forced vital 
capacity.
Values are mean ± SD unless otherwise indicated.
*p= comparison of atopic and nonatopic patients within the group.
¶p= comparison of four groups.
†p=0.01, ‡p=0.05.
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Because the FEV1/FVC ratio is commonly used as a 
measure of the degree of airflow obstruction and severity of 
asthma, as BMI increases, the FEV1/FVC ratio decreases, 
leading to more limited airflow (11,24). Davidson et al. 
(25) demonstrated that obese participants had the lowest 
FEV1/FVC ratio in children and adolescents. Lang et al. 
(18) showed that overweight/obese children reported 
clinically and statistically worse symptoms than those 
lean participants. Atopy is an important host factor in the 
development of asthma, and it has been shown that the 
effect of obesity on asthma is stronger among nonatopic 
individuals than among those with atopy (26,27). In our 
study nonatopic obese patients had the lowest FEV1/FVC 
ratio compared with atopic and nonatopic lean patients 
with asthma. Moreover, in the nonatopic obese asthma 
subgroup, an increase in relBMI together with a decrease 
in FEV1/FVC resulted in more limitation of airflow and 
airway obstruction. The more severe asthma is, the less 
response to therapy is expected. Therefore, symptoms of 
nonatopic obese asthmatic children should be questioned 
in detail. 
Ye et al. (28) concluded that ICS can improve large 
airway function in normal weight children with asthma. 
However, ICS has no effect on small airway function and 
obesity restrains the effect of ICS in children with asthma. 
We believe that ICS improves airway function mainly in 
atopic patients and obesity restrains the effect of ICS in 
only nonatopic patients. Visness et al. (26) identified that 
obesity was significantly related to current asthma among 
children and adolescents, and the association was stronger 
in nonatopic children than in atopic children. In the 
current study, the FEV1/FVC ratio was significantly lower 
in nonatopic obese patients with asthma than in atopic 
obese patients with asthma. Additionally, the FEV1/FVC 
ratio was significantly lower in nonatopic obese patients 
than in atopic lean patients with asthma. The presence of 
atopy appears to result in a higher FEV1/FVC ratio. Since 
all of the patients were using ICSs, we posit that inhaled 
steroids may be more effective in obese atopic children 
with asthma and could lead to a decrease in limitation 
of airflow. ICS may have a limited effect on pulmonary 
function in nonatopic obese children with asthma. The 
lower the FEV1/FVC ratio, the more easily symptoms 
may be recognized. Symptoms should be more carefully 
addressed in nonatopic obese asthmatic patients. 
Several studies have suggested that obese patients 
with asthma constitute a specific phenotype of patients 
in either early-onset or late-onset (29,30). In our study, 
most of the patients with asthma had an early-onset 
phenotype. In the Severe Asthma Research Program study, 
age at onset of asthma affected the relationship between 
obesity and asthma (31).Obese subjects with early-onset 
asthma (<12 years) are characterized by a higher level of 
airway obstruction and bronchial hyper-responsiveness 
compared with obese subjects with late-onset asthma (>12 
years) (21). In our study, in obese patients, only eight had 
onset of asthma at ≥12 years. The two groups of patients 
could not be compared because of the small numbers, 
as well as significant age and BMI/relBMI differences 
between them.
The relationship between obesity and pulmonary 
function appears to be affected by sex. Tantisira et al. 
showed that obesity is associated with limitation of airflow 
and a reduced FEV1/FVC ratio, mainly in girls (14,11). 
The incidence and severity of asthma are greater in 
preadolescent boys, but the relationship between obesity 
and asthma appears to be more prevelant in girls (32,33). 
Throughout childhood, girls have a larger airway in 
relation to lung size than boys, a phenomenon that begins 
to reverse in adolescence (34). With a particular BMI, girls 
also have a significantly higher amount of percentage body 
fat than boys (35). Beydon and Delclaux (21) suggested 
that a specific relationship between BMI and the FEV1/
FVC ratio in girls could be explained by obesity-related 
earlier puberty and growth spurts, resulting in a higher 
BMI, increased FEV1 and FVC (FVC was increased more 
than FEV1), and a lower FEV1/FVC ratio. However, in 
our study, we did not find these correlations according to 
sex. In our study, the distribution of age was mainly <10 
years and the distribution of fat is different in girls at these 
ages. Therefore, pulmonary function parameters were not 
affected. We recommend using relBMI or BMI z scores 
instead of BMI in asthma studies to prevent bias. 
Strengths of our study were using relBMI for comparing 
obese and lean children with asthma and investigating effect 
of atopy presence on pulmonary function. Limitations of 
our study were having small sample size, cross-sectional 
design and having no correlation with clinical symptoms. 
Future research with larger sample size is needed to define 
our results more clearly. 
In conclusion, this cross-sectional study showed 
no differences in pulmonary function test parameters 
between obese and lean children with well-controlled mild 
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persistent asthma, suggesting that there is no relationship 
between relBMI and pulmonary function. However, 
nonatopic obese children with asthma appear to be most 
negatively affected indicating that effect of obesity on 
asthma is stronger among nonatopic individuals and 
absence of atopy is an important factor for the airway 
obstruction in obese patients with asthma. 
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